Y Trademark

Trademark Overview

On Monday, November 23, 2020, a trademark application was filed for Y with the United States Patent and Trademark Office. The USPTO has given the Y trademark a serial number of 90336990. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2024. This trademark is owned by EpiBone, Inc.. The Y trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services, namely, culturing cells and biological tissues for medical or clinical purposes; Medical services, namely, culturing human mesenchymal stem cells for bone graft regeneration in humans; Medical services, namely, culturing human cells for seeding bone scaffolds for medical or clinical purposes, and for bone graft engineering and surgical implantation in humans
y

General Information

Serial Number90336990
Word MarkY
Filing DateMonday, November 23, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements

Description of MarkThe mark consists of stylized bone segment with a "Y" shaped artery running through it.
Goods and ServicesMedical services, namely, culturing cells and biological tissues for medical or clinical purposes; Medical services, namely, culturing human mesenchymal stem cells for bone graft regeneration in humans; Medical services, namely, culturing human cells for seeding bone scaffolds for medical or clinical purposes, and for bone graft engineering and surgical implantation in humans

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 28, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEpiBone, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrooklyn, NY 11226
Party NameEpiBone, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrooklyn, NY 11226

Trademark Events

Event DateEvent Description
Monday, March 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 10, 2023SOU EXTENSION 4 GRANTED
Thursday, August 10, 2023SOU EXTENSION 4 FILED
Thursday, August 10, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 6, 2023SOU EXTENSION 3 GRANTED
Monday, February 6, 2023SOU EXTENSION 3 FILED
Monday, February 6, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 2, 2022SOU EXTENSION 2 GRANTED
Tuesday, August 2, 2022SOU EXTENSION 2 FILED
Tuesday, August 2, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 4, 2022SOU EXTENSION 1 GRANTED
Friday, February 4, 2022SOU EXTENSION 1 FILED
Friday, February 4, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 10, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 6, 2021ASSIGNED TO EXAMINER
Friday, January 29, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, January 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 26, 2020NEW APPLICATION ENTERED

Related Keywords

medical bone culturing cells services namely graft humans human clinical